116 related articles for article (PubMed ID: 31031178)
21. Vascular effects of calcium channel antagonists: new evidence.
Richard S
Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
[TBL] [Abstract][Full Text] [Related]
22. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
Sidach SS; Mintz IM
J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
[TBL] [Abstract][Full Text] [Related]
23. Transient and big are key features of an invertebrate T-type channel (LCav3) from the central nervous system of Lymnaea stagnalis.
Senatore A; Spafford JD
J Biol Chem; 2010 Mar; 285(10):7447-58. PubMed ID: 20056611
[TBL] [Abstract][Full Text] [Related]
24. Two New Classes of T-Type Calcium Channel Inhibitors with New Chemical Scaffolds from Ganoderma cochlear.
Zhou FJ; Nian Y; Yan Y; Gong Y; Luo Q; Zhang Y; Hou B; Zuo ZL; Wang SM; Jiang HH; Yang J; Cheng YX
Org Lett; 2015 Jun; 17(12):3082-5. PubMed ID: 26024438
[TBL] [Abstract][Full Text] [Related]
25. T-type Ca²⁺ channels regulate the exit of cardiac myocytes from the cell cycle after birth.
Wang F; Gao H; Kubo H; Fan X; Zhang H; Berretta R; Chen X; Sharp T; Starosta T; Makarewich C; Li Y; Molkentin JD; Houser SR
J Mol Cell Cardiol; 2013 Sep; 62():122-30. PubMed ID: 23743021
[TBL] [Abstract][Full Text] [Related]
26. Iron overload and apoptosis of HL-1 cardiomyocytes: effects of calcium channel blockade.
Chen MP; Cabantchik ZI; Chan S; Chan GC; Cheung YF
PLoS One; 2014; 9(11):e112915. PubMed ID: 25390893
[TBL] [Abstract][Full Text] [Related]
27. T-type channels in cancer cells: Driving in reverse.
Alza L; Visa A; Herreros J; Cantí C
Cell Calcium; 2022 Jul; 105():102610. PubMed ID: 35691056
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of recombinant Ca(v)3.1 (alpha(1G)) T-type calcium channels by the antipsychotic drug clozapine.
Choi KH; Rhim H
Eur J Pharmacol; 2010 Jan; 626(2-3):123-30. PubMed ID: 19782679
[TBL] [Abstract][Full Text] [Related]
29. Modulation of T-type Ca2+ channels by Lavender and Rosemary extracts.
El Alaoui C; Chemin J; Fechtali T; Lory P
PLoS One; 2017; 12(10):e0186864. PubMed ID: 29073181
[TBL] [Abstract][Full Text] [Related]
30. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.
Lee JH; Gomora JC; Cribbs LL; Perez-Reyes E
Biophys J; 1999 Dec; 77(6):3034-42. PubMed ID: 10585925
[TBL] [Abstract][Full Text] [Related]
31. In vitro cytotoxicity on human ovarian cancer cells by T-type calcium channel blockers.
Jang SJ; Choi HW; Choi DL; Cho S; Rim HK; Choi HE; Kim KS; Huang M; Rhim H; Lee KT; Lee JY
Bioorg Med Chem Lett; 2013 Dec; 23(24):6656-62. PubMed ID: 24220170
[TBL] [Abstract][Full Text] [Related]
32. Ca
Tracy ME; Tesic V; Stamenic TT; Joksimovic SM; Busquet N; Jevtovic-Todorovic V; Todorovic SM
Neuropharmacology; 2018 Jun; 135():343-354. PubMed ID: 29578032
[TBL] [Abstract][Full Text] [Related]
33. Three for T: molecular analysis of the low voltage-activated calcium channel family.
Perez-Reyes E
Cell Mol Life Sci; 1999 Nov; 56(7-8):660-9. PubMed ID: 11212313
[TBL] [Abstract][Full Text] [Related]
34. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
Perez-Reyes E; Van Deusen AL; Vitko I
J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
[TBL] [Abstract][Full Text] [Related]
35. Effect of mibefradil on sodium and calcium currents.
Strege PR; Bernard CE; Ou Y; Gibbons SJ; Farrugia G
Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G249-53. PubMed ID: 15790762
[TBL] [Abstract][Full Text] [Related]
36. Five different profiles of dihydropyridines in blocking T-type Ca(2+) channel subtypes (Ca(v)3.1 (alpha(1G)), Ca(v)3.2 (alpha(1H)), and Ca(v)3.3 (alpha(1I))) expressed in Xenopus oocytes.
Furukawa T; Nukada T; Namiki Y; Miyashita Y; Hatsuno K; Ueno Y; Yamakawa T; Isshiki T
Eur J Pharmacol; 2009 Jun; 613(1-3):100-7. PubMed ID: 19401195
[TBL] [Abstract][Full Text] [Related]
37. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
[TBL] [Abstract][Full Text] [Related]
38. 3D QSAR studies on 3,4-dihydroquinazolines as T-type calcium channel blocker by comparative molecular similarity indices analysis (CoMSIA).
Jeong JA; Cho H; Jung SY; Kang HB; Park JY; Kim J; Choo DJ; Lee JY
Bioorg Med Chem Lett; 2010 Jan; 20(1):38-41. PubMed ID: 19951839
[TBL] [Abstract][Full Text] [Related]
39. A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
Gackière F; Bidaux G; Lory P; Prevarskaya N; Mariot P
Cell Calcium; 2006 Apr; 39(4):357-66. PubMed ID: 16442617
[TBL] [Abstract][Full Text] [Related]
40. Common mechanisms of drug interactions with sodium and T-type calcium channels.
Bladen C; Zamponi GW
Mol Pharmacol; 2012 Sep; 82(3):481-7. PubMed ID: 22695716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
